Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical and Experimental Immunology

• Publication date

  2006-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.2005.03000.xPMID 16412064PMCID PMC1809583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunostimulatory cellular responses of cured Leishmania‐infected patients and hamsters against the integral membrane proteins and non‐membranous soluble proteins of a recent clinical isolate of Leishmania donovani

  2005cited by this paper
• Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.

  2005cited by this paper
• Human S-antigen: peptide determinant recognition in uveitis patients.

  2004cited by this paper
• Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.

  2004cited by this paper
• Vaccination with Phosphoglycan-Deficient Leishmania major Protects Highly Susceptible Mice from Virulent Challenge without Inducing a Strong Th1 Response1

  2004cited by this paper
• Role for CD4+ CD25+ Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity

  2004cited by this paper
• The Leishmania mexicana Cysteine Protease, CPB2.8, Induces Potent Th2 Responses 1

  2003cited by this paper
• Experimental canine leishmaniasis: evolution of infection following re-challenge with Leishmania infantum.

  2003cited by this paper
• Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant.

  2002cited by this paper
• The immunology of susceptibility and resistance to Leishmania major in mice

  2002cited by this paper
• CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

  2002cited by this paper
• The Role of IL-10 in Promoting Disease Progression in Leishmaniasis1

  2001cited by this paper
• Vervet Monkeys Vaccinated with Killed Leishmania major Parasites and Interleukin-12 Develop a Type 1 Immune Response but Are Not Protected against Challenge Infection

  2001cited by this paper
• The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure

  2001cited by this paper
• Protection against Cutaneous Leishmaniasis Induced by Recombinant Antigens in Murine and Nonhuman Primate Models of the Human Disease

  2001cited by this paper
• Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani.

  2001cited by this paper
• Regulatory Role of T Cells Producing both Interferon γ and Interleukin 10 in Persistent Infection

  2001cited by this paper
• Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning1

  2001cited by this paper
• Distinct Innate and Acquired Immune Responses to Leishmania in Putative Susceptible and Resistant Human Populations Endemically Exposed to L. (Viannia) panamensis Infection

  2000cited by this paper
• A Novel Leishmania infantum Recombinant Antigen Which Elicits Interleukin 10 Production by Peripheral Blood Mononuclear Cells of Patients with Visceral Leishmaniasis

  2000cited by this paper
• Leishmania‐specific T cells expressing interferon‐gamma (IFN‐γ) and IL‐10 upon activation are expanded in individuals cured of visceral leishmaniasis

  1999cited by this paper
• T-cell response in human leishmaniasis.

  1999cited by this paper
• T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant leishmania antigens.

  1999cited by this paper
• Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia

  1999cited by this paper
• Epidemiology of visceral leishmaniasis in India.

  1999cited by this paper
• Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.

  1998cited by this paper
• High levels of plasma IL‐10 and expression of IL‐10 by keratinocytes during visceral leishmaniasis predict subsequent development of post‐kala‐azar dermal leishmaniasis

  1998cited by this paper
• Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.

  1996cited by this paper
• Resistance to Leishmania major Induced by Tolerance to a Single Antigen

  1996cited by this paper
• Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis.

  1996cited by this paper
• IL-12 enhances Th1-type responses in human Leishmania donovani infections.

  1995cited by this paper
• Expression cloning of a protective Leishmania antigen.

  1995cited by this paper
• Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections

  1995cited by this paper
• Identification of Leishmania chagasi antigens recognized by human lymphocytes.

  1995cited by this paper
• Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.

  1994cited by this paper
• Interleukin 10 production correlates with pathology in human Leishmania donovani infections.

  1993cited by this paper
• Immunology of leishmaniasis.

  1993cited by this paper
• Cytokine patterns in the pathogenesis of human leishmaniasis.

  1993cited by this paper
• Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

  1993cited by this paper
• Immunology of leishmaniasis.

  1992cited by this paper
• Leishmania chagasi antigens recognized in cured visceral leishmaniasis and asymptomatic infection.

  1992cited by this paper
• IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.

  1991cited by this paper
• Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection

  1991cited by this paper
• Development of vaccines against leishmaniasis.

  1990cited by this paper
• In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease.

  1990cited by this paper
• Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production.

  1990cited by this paper
• Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.

  1989cited by this paper
• A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles.

  1987cited by this paper
• Immunology of leishmaniasis.

  1971cited by this paper

• Potential biomarkers of immune protection in human leishmaniasis

  2021cites this paper
• A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein.

  2019cites this paper
• Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.

  2017cites this paper
• Immunoprotective responses of T helper type 1 stimulatory protein‐S‐adenosyl‐L‐homocysteine hydrolase against experimental visceral leishmaniasis

  2016cites this paper
• Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs

  2016cites this paper
• Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani

  2016cites this paper
• Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis

  2014cites this paper
• A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis.

  2012cites this paper
• Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters

  2012influential citation
• Anti-leishmanial and toxicity activities of some selected Iranian medicinal plants

  2012cites this paper
• Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites

  2011cites this paper
• Immunity to Visceral Leishmaniasis

  2011cites this paper
• Prophylactic Efficacy of High‐Molecular‐Weight Antigenic Fractions of a Recent Clinical Isolate of Leishmania donovani Against Visceral Leishmaniasis

  2008cites this paper
• Induction of Th1-type cellular responses in cured/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa.

  2008cites this paper
• Immunomodulatory effect of antigenic fractions of a recent clinical isolate of L. donovani on monocytic cell lines

  2008cites this paper
• Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.

  2006cites this paper